Physician profile
Thomas Michael Wiley
NPI 1144285123
$3,663.40
in general payments reported to CMS, 2019-2025
37 companies · $152 in 2025
The $152 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $845 · 2020: $332 · 2021: $593 · 2022: $646 · 2023: $566 · 2024: $529 · 2025: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,246.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $392.91 | 2019-2024 | Aveir, Gallant, Jot Dx |
| Janssen Pharmaceuticals, INC | $335.08 | 2019-2022 | |
| Atricure, INC. | $329.57 | 2022-2024 | |
| E.R. Squibb & Sons, L.L.C. | $314.56 | 2019-2023 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $275.03 | 2019-2025 | |
| Pfizer INC. | $249.38 | 2019-2025 | |
| Amgen INC. | $212.17 | 2019-2025 | Repatha |
| Abiomed | $180.70 | 2024-2025 | Impella |
| Biosense Webster, INC. | $151.50 | 2023-2024 | Carto 3, Nuvision Ice Catheter |
| Sanofi-Aventis U.S. LLC | $102.58 | 2019-2023 | |
| Astrazeneca Pharmaceuticals Lp | $99.83 | 2019-2023 | Farxiga |
| Lundbeck LLC | $92.71 | 2019-2020 | |
| Medtronic Vascular, INC. | $79.33 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $72.03 | 2021-2025 | Verquvo |
| Lexicon Pharmaceuticals, INC. | $71.86 | 2023-2024 | Inpefa |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Wiley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.